Manstein, Dietmar J. http://orcid.org/0000-0003-0763-0147
Meiring, J. C. M.
Hardeman, E. C.
Gunning, Peter W.
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (MA 1081/21-1, MA 1081/22-1, EXC 2155 “RESIST” – Project ID 39087428)
National Health and Medical Research Council (APP1004188)
Article History
Received: 21 January 2019
Accepted: 23 April 2019
First Online: 4 May 2019
Compliance with ethical standards
:
: PW.G and E.C.H are directors and shareholders of TroBio Therapeutics Pty Ltd, a company that is commercializing anti-tropomyosin drugs for the treatment of cancer and their laboratories receive funding from TroBio to evaluate anti-tropomyosin drug candidates. J.C.M.M. and D.J.M. declare no financial competing interests. All authors declare no non-financial competing interests.